09-14-2018 03:32 PM CET - Health & Medicine
Print

Global Anti-Cancer Drug Market Rising Demand For Upcoming Years | Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer

Press release from: Anti-Cancer Drug



Qyresearchreports include new market research report “Global Anti-Cancer Drug Market Professional Survey Report 2018” to its huge collection of research reports.

Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.

Interpret a Competitive Analysis with Sample Report : www.qyresearchreports.com/sample/sample.php?rep_id=188551...

The global Anti-Cancer Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Avastin
Rituxan
Herceptin
Alimta

By Application, the market can be split into
Hospital
Clinic
Home Care

The study objectives of this report are:

To analyze and study the global Anti-Cancer Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Anti-Cancer Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

Read Comprehensive Overview of Report @ www.qyresearchreports.com/report/global-anti-cancer-drug-...

Key Stakeholders
Anti-Cancer Drug Manufacturers
Anti-Cancer Drug Distributors/Traders/Wholesalers
Anti-Cancer Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Web: www.qyresearchreports.com
Email: sales@qyresearchreports.com

This release was published on openPR.
News-ID: 1240194 • Views: 162
More releases More releases

You can edit or delete your press release here: